503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-8.43%
Negative net income growth while ZETA stands at 40.68%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
185.62%
Some D&A expansion while ZETA is negative at -1.61%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-331.97%
Negative yoy working capital usage while ZETA is 0.00%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-331.97%
Negative yoy usage while ZETA is 100.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-96.63%
Both negative yoy, with ZETA at -192.80%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-60.82%
Negative yoy CFO while ZETA is 20.83%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
6.49%
Lower CapEx growth vs. ZETA's 14.14%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
No Data
No Data available this quarter, please select a different quarter.
1.37%
Purchases growth of 1.37% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
1.93%
Liquidation growth of 1.93% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
No Data
No Data available this quarter, please select a different quarter.
9.18%
We have mild expansions while ZETA is negative at -18.84%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-7.88%
Negative yoy issuance while ZETA is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-7200.00%
Both yoy lines negative, with ZETA at -23.83%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.